Rimonabant in obese patients with type 2 diabetes [letter]

D Roberfroid

doi:10.1016/S0140-6736(07)60261-X

Rimonabant in obese patients with type 2 diabetes [letter]

D Roberfroid

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Lancet
Volume	369
Issue number	9561
Pages (from-to)	553
ISSN	0140-6736
DOIs	https://doi.org/10.1016/S0140-6736(07)60261-X
Publication status	Published - 2007

Keywords

B780-tropical-medicine
Endocrine disorders
Diabetes mellitus type 2
Complications
Obesity
Drug therapy
Rimonabant
Effectiveness
Tolerability

Access to Document

10.1016/S0140-6736(07)60261-X

http://lib.itg.be/pdf/itg/2007/2007lanc0553.pdf

Cite this

@article{840bbcb0a9964db6a6f2bf1f68a1d714,

title = "Rimonabant in obese patients with type 2 diabetes [letter]",

keywords = "B780-tropical-medicine, Endocrine disorders, Diabetes mellitus type 2, Complications, Obesity, Drug therapy, Rimonabant, Effectiveness, Tolerability",

author = "D Roberfroid",

note = "ITG-H1A; HEALTH; U-VOED; JIF; DOI; PDF",

year = "2007",

doi = "10.1016/S0140-6736(07)60261-X",

language = "English",

volume = "369",

pages = "553",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9561",

}

TY - JOUR

T1 - Rimonabant in obese patients with type 2 diabetes [letter]

AU - Roberfroid, D

N1 - ITG-H1A; HEALTH; U-VOED; JIF; DOI; PDF

PY - 2007

Y1 - 2007

KW - B780-tropical-medicine

KW - Endocrine disorders

KW - Diabetes mellitus type 2

KW - Complications

KW - Obesity

KW - Drug therapy

KW - Rimonabant

KW - Effectiveness

KW - Tolerability

U2 - 10.1016/S0140-6736(07)60261-X

DO - 10.1016/S0140-6736(07)60261-X

M3 - Letter

SN - 0140-6736

VL - 369

SP - 553

JO - Lancet

JF - Lancet

IS - 9561

ER -